Literature DB >> 7541102

Galanin and somatostatin inhibition of neurokinin A and B induced airway mucus secretion in the rat.

U Wagner1, H C Fehmann, D Bredenbröker, F Yu, P J Barth, P von Wichert.   

Abstract

Neurokinin A and B are present in neurons situated in lung and NK-1 receptors have been described on tracheal submucosal gland cells. In the present study we compared the ability of substance P (SP), neurokinin A (NKA) and neurokinin B (NKB) to stimulate airway mucus secretion. Furthermore, we characterized the interaction of NKA and NKB with galanin and somatostatin. The rank order of the tachykinins to stimulate airway mucus secretion was SP > NKA > NKB suggesting that NK-1 receptors mediate these effects(EC50:SP: 50 nmol/l, NKA: 200 nmol/l, NKB: 400 nmol/l). Galanin and somatostatin were equally potent to inhibit NK-A and NK-B stimulated airway mucus release. These results suggest that NK-A and NK-B are potent stimulators of airway macromolecule secretion. Galanin and somatostatin potently inhibit these actions of the tachykinins. Therefore, airway mucus secretion is controlled by a complex network of several different mediators.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541102     DOI: 10.1016/0024-3205(95)00271-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  Tachykinin NK3 and NK1 receptor activation elicits secretion from porcine airway submucosal glands.

Authors:  Jonathan E Phillips; John A Hey; Michel R Corboz
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

2.  Analysis of airway secretions in a model of sulfur dioxide induced chronic obstructive pulmonary disease (COPD).

Authors:  Ulrich Wagner; Petra Staats; Hans-Christoph Fehmann; Axel Fischer; Tobias Welte; David A Groneberg
Journal:  J Occup Med Toxicol       Date:  2006-06-07       Impact factor: 2.646

3.  Effect of montelukast on platelet activating factor- and tachykinin induced mucus secretion in the rat.

Authors:  Rene Schmidt; Petra Staats; David A Groneberg; Ulrich Wagner
Journal:  J Occup Med Toxicol       Date:  2008-02-20       Impact factor: 2.646

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.